USPTO serial 88775980
NANOPATCH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEGGS, MONICA L
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with NANOPATCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Trade Zone, Shanghai,, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yue (Robert) Xu
YUE (ROBERT) XU APEX ATTORNEYS AT LAW, LLP160 ALAMO PLAZA #942ALAMO, CA 94507UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; Devices for monitoring blood glucose for medical purposes; Injection needles for interstitial fluid; Medical diagnostic apparatus for testing blood glucose levels; Needle-based and needle-free injection systems; Medical test kits for diabetes monitoring for home use; Medical needles and introducers; Medical instruments to measure blood glucose level and other physiological and cardiovascular parameters; Probes for medical purposes, specifically for monitoring interstitial fluid glucose levels; Medical instruments for measuring and displaying blood glucose level or other physiological parameters; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus for introducing pharmaceutical preparations into the human body | ACTIVE | Sep 16, 2019 |
| 044 | Provision of medical services by health care professionals via the internet or telecommunication networks; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Dietary and nutritional guidance; Medical assistance services provided via telecommunication and global computer networks for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; Providing limited in-home personal medical services for individuals including checking vital signs, medication compliance and individual hygiene, checking medical equipment and supplies, and providing on-line information related to these personal medical services; Medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Medical diagnostic testing, monitoring and reporting services; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing of urine, blood, hair follicles and breath; Medical testing for diagnostic or treatment purposes in the field of diabetes; Providing information in the field of diabetes | ACTIVE | Sep 16, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 4, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 23, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 31, 2020 | NWAP | NEW APPLICATION ENTERED | — |